EACS 2025

The 20th European AIDS Conference (EACS 2025), organised by the European AIDS Clinical Society, was held in Paris, France from 15 to 18 October.

Global health targets

More Europeans are dying from HIV now than 15 years ago

21 October 2025

Treatment guidelines

New European HIV guidelines address sleep, obesity and breastfeeding

27 October 2025

Chemsex & recreational drug use

Chemsex use is changing in Europe

4 November 2025

Sexually transmitted infections epidemiology

Increased STI diagnoses in gay men with HIV are mainly due to more testing

4 November 2025

Sexually transmitted infections prevention

STIs and doxyPEP at EACS: community effectiveness, gonorrhoea resistance and ‘blunted’ syphilis

3 November 2025

Weight gain & lipodystrophy

Less weight gain with Dovato than Biktarvy

3 November 2025

Cardiovascular disease

Too few people with HIV receiving statins despite guideline changes

29 October 2025

Cancer

Tailored cancer screening strategies needed for people with HIV

28 October 2025

Improving HIV care

Three ways Ukraine is using AI to improve HIV services

28 October 2025

Hepatitis B

Hepatitis B reactivation is rare after switching from tenofovir, two European studies show

24 October 2025

The search for a cure

Second Berlin patient has unusual immune response that seems to have removed his HIV

23 October 2025

Resistance

Resistance following failure of injectable cabotegravir/rilpivirine may limit future treatment options

22 October 2025

Quality of life

EACS 2025

More Europeans are dying from HIV now than 15 years ago

New European HIV guidelines address sleep, obesity and breastfeeding

Chemsex use is changing in Europe

Increased STI diagnoses in gay men with HIV are mainly due to more testing

STIs and doxyPEP at EACS: community effectiveness, gonorrhoea resistance and ‘blunted’ syphilis

Less weight gain with Dovato than Biktarvy

Too few people with HIV receiving statins despite guideline changes

Tailored cancer screening strategies needed for people with HIV

Three ways Ukraine is using AI to improve HIV services

Hepatitis B reactivation is rare after switching from tenofovir, two European studies show

Second Berlin patient has unusual immune response that seems to have removed his HIV

Resistance following failure of injectable cabotegravir/rilpivirine may limit future treatment options

People with HIV report little difference in quality of life compared with matched controls, but more depression

Conference bulletins

English

News from EACS 2025, November 2025

Interview with Esteban Martinez: EACS Guideline Updates

Are Europe’s Migrants Acquiring HIV After Arrival?

Weekly Oral HIV Treatment Looks Good at Two Years

New guidance from ECDC and EACS aims to raise standards of HIV care, focusing on lifelong health

Europe: Final report from the audit of the HIV pre-exposure prophylaxis standards of care

Are Cabotegravir Injections More Tolerable Than Lenacapavir?